HealthEquity administers health savings accounts (HSAs) and related benefits, earning custodial and transaction fees on the assets it holds for employers and their employees. The moat is the platform itself: once an employer and its workforce are enrolled, switching custodians is costly and rare, and that stickiness shows up in a 71.2% gross margin and a 28.4% operating margin. Revenue growth of 7.6% is steady rather than explosive, and the forward P/E of 19.7 against a trailing 33.5 suggests the market expects earnings to catch up with that top line. At a $7.7B market cap with no index membership, the name sits in a space where coverage is thinner and mispricings can persist, which makes it worth a closer look at whether the margin profile is durable and how much of the earnings step-up the consensus has already priced in. ROE of 11.4% is the figure to pressure-test, since it is modest for a business with margins this high.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 19 Oct 2026, 18:04 CEST | Rating | Fairly valued | first publication | $92.03 |
| 10 Oct 2026, 00:00 CEST | Fair value | $85.23 | $87.96 | $93.05 |
| 10 Oct 2026, 00:00 CEST | ACCE price target | $94.00 | first publication | $93.05 |
| 6 Oct 2026, 00:00 CEST | Fair value | $87.96 | $89.09 | $90.04 |
| 24 Sept 2026, 00:00 CEST | Fair value | $89.09 | $90.70 | $91.75 |
| 21 Sept 2026, 00:00 CEST | Fair value | $90.70 | $92.28 | $95.14 |
| 18 Sept 2026, 00:00 CEST | Fair value | $92.28 | $93.29 | $96.00 |
| 13 Sept 2026, 00:00 CEST | Fair value | $93.29 | $91.62 | $96.26 |
| 10 Sept 2026, 00:00 CEST | Fair value | $91.62 | $93.79 | $93.36 |
| 31 Aug 2026, 00:00 CEST | Fair value | $93.79 | $168 | $96.37 |
Answered from HealthEquity Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity Inc. Common Stock | $103.97 | $85 | 22% above | 35.3x | 11.4% | 78 | 66 |
| 2413.T M3, Inc. | ¥1934.50 | - | - | 28.2x | 12.0% | 74 | 56 |
| HNGE Hinge Health Inc. Class A Common Stock | $109.93 | $163 | 33% below | 36.3x | 30.4% | 93 | 70 |
| TEM Tempus AI Inc. Class A Common Stock | $63.81 | - | - | - | -67.4% | 33 | 41 |
| DOCS Doximity Inc. Class A Common Stock | $33.68 | $29 | 17% above | 39.6x | 17.2% | 86 | 57 |
| BTSG BrightSpring Health Services Inc. Common Stock | $60.86 | $35 | 72% above | 54.6x | 13.0% | 44 | 69 |
| WAY Waystar Holding Corp. Common Stock | $28.98 | $24 | 21% above | 41.4x | 3.8% | 66 | 67 |
Where HQY ranks against its sector peers on each metric.